Aloracetam
Obscure experimental racetam-related compound that Aventis studied for Alzheimer's; virtually no human data.
Pharmacology
Contents
DETAILED OVERVIEW
What is Aloracetam?
Aloracetam is an obscure, experimental nootropic that Aventis investigated for the treatment of Alzheimer's disease, but it was never marketed and development was discontinued. Despite the name it is not a classic racetam structurally: it lacks the pyrrolidone ring that defines the family. Its mechanism of action is essentially uncharacterized in the public literature; beyond a proposed but unconfirmed cholinergic action there is little reliable data. Published human clinical evidence is essentially absent, so this entry serves as reference only.
Mechanism
Uncharacterized (proposed cholinergic)
Half-life
N/A
Onset
N/A
Legal status
Unapproved medicine; unscheduled in the US
There is virtually no meaningful community or anecdotal experience with Aloracetam: it is an obscure, never-commercialized experimental compound that is rarely sourced or documented. The few online mentions typically extrapolate from the side-effect profile of other racetams (for example cholinergic headache) rather than from real, repeated user reports. Any description of perceived effects should therefore be treated with strong skepticism, and this entry is a reference, not a usage guide.
⚠ Not clinical evidence – based on user accounts.
Receptor profile
- Acetylcholine systemWeak
- AMPA receptorsWeak
Safety
Side effects, stop signs, contraindications
Side effects · 3
- With virtually no human data, the side-effect profile is unknown; racetam-like effects such as headache are plausible but unconfirmed
- Theoretical choline-depletion headache, as with other racetams; a choline source may help in principle
- Unknown long-term safety: never marketed and development was discontinued
Contraindications · 3
- Pregnancy and breastfeeding: no safety data, should be avoided
- Not a medicine: human clinical trials have not established its safety, any use is experimental
- Unknown drug interactions: the mechanism is uncharacterized, so co-administration risk cannot be estimated
Related Nootropics
Same therapeutic category
FAQ
FAQ
Aloracetam is an obscure experimental compound that a pharmaceutical company once studied as a potential Alzheimer's treatment, but development was discontinued and it was never brought to market. In theory it might support memory and cognition through a brain-chemistry pathway, but this was essentially never tested in humans, so today it's mostly a research and historical curiosity rather than a proven, ready-to-use substance.
Telegram
Have a question about Aloracetam?
Reach out to us on Telegram for a personalized stack. We'll be happy to help.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
Structure & chemistry
The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.